(Q43892844)

27 November 2017

Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate (English)

1 reference

27 November 2017

0 references

Michael J Tolentino

1

1 reference

27 November 2017

D Scott McLeod

2

1 reference

27 November 2017

Makoto Taomoto

3

1 reference

27 November 2017

Tsuyoshi Otsuji

4

1 reference

27 November 2017

Anthony P Adamis

5

1 reference

27 November 2017

Gerard A Lutty

6

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

American Journal of Ophthalmology

27 November 2017

1 reference

27 November 2017

133

1 reference

27 November 2017

3

1 reference

27 November 2017

373-385

1 reference

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

Localization of vascular endothelial growth factor in human retina and choroid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

VEGF localisation in diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic retino

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

A New Technique for Visualization of the Human Retinal Vasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

Three dimensional analysis of microaneurysms in the human diabetic retina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

Histopathology of diabetic retinopathy in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

Arterial gene transfer of naked DNA for therapeutic angiogenesis: early clinical results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

Therapeutic myocardial angiogenesis via vascular endothelial growth factor gene therapy: moving on down the road

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901381-2

10.1016/S0002-9394(01)01381-2

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference